Willow Historical Cash Flow
| WLLW Stock | CAD 0.07 0.01 6.25% |
Analysis of Willow Biosciences cash flow over time is an excellent tool to project Willow Biosciences future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Non Cash Items of 76 K or Capital Expenditures of 642.1 K as it is a great indicator of Willow Biosciences ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Willow Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Willow Biosciences is a good buy for the upcoming year.
Willow |
About Willow Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Willow balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Willow's non-liquid assets can be easily converted into cash.
Willow Biosciences Cash Flow Chart
Add Fundamental
Change In Working Capital
The difference in the amount of working capital from one period to the next, indicating the change in a company's short-term assets and liabilities.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Willow Biosciences financial statement analysis. It represents the amount of money remaining after all of Willow Biosciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from Willow Biosciences' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Willow Biosciences current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Willow Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Willow Biosciences' Change To Operating Activities is very stable compared to the past year.
| 2021 | 2022 | 2023 | 2024 (projected) | Stock Based Compensation | 1.7M | 1.5M | 420K | 781.8K | Depreciation | 3.2M | 2.6M | 1.8M | 1.9M |
Willow Biosciences cash flow statement Correlations
Click cells to compare fundamentals
Willow Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Willow Biosciences cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Free Cash Flow | (15.9M) | (13.8M) | (20.0M) | (14.5M) | (11.5M) | (11.0M) | |
| Change In Working Capital | (351.0K) | (211K) | (316K) | 129K | (207K) | (196.7K) | |
| Other Cashflows From Financing Activities | 8.4M | 25K | 8.0M | (723K) | (64K) | (60.8K) | |
| Other Non Cash Items | 32.6M | 40K | 27K | (3.3M) | 80K | 76K | |
| Capital Expenditures | 6.7M | 997K | 1.8M | 682K | 619K | 642.1K | |
| Total Cash From Operating Activities | (9.2M) | (12.8M) | (18.2M) | (13.9M) | (10.9M) | (10.4M) | |
| Net Income | (44.6M) | (33.9M) | (6.1M) | (14.8M) | (13.0M) | (12.4M) | |
| Total Cash From Financing Activities | 35.3M | 9.9M | 34.1M | (723K) | (318K) | (302.1K) | |
| Change In Cash | 19.3M | (3.7M) | 14.2M | (19.1M) | (7.9M) | (7.5M) | |
| End Period Cash Flow | 19.6M | 15.9M | 30.1M | 11.0M | 3.1M | 3.8M | |
| Begin Period Cash Flow | 372.3K | 19.6M | 15.9M | 30.1M | 11.0M | 11.6M | |
| Depreciation | 2.2M | 3.2M | 3.2M | 2.6M | 1.8M | 1.9M | |
| Stock Based Compensation | 2.6M | 951K | 1.7M | 1.5M | 420K | 781.8K | |
| Total Cashflows From Investing Activities | (6.8M) | (837K) | (1.7M) | (4.6M) | (4.1M) | (3.9M) | |
| Net Borrowings | (493K) | (651K) | (637K) | (723K) | (650.7K) | (618.2K) | |
| Change To Operating Activities | (352K) | (211K) | (316K) | 129K | 116.1K | 121.9K | |
| Change To Netincome | 33.6M | 18.2M | (15.0M) | (1.8M) | (1.6M) | (1.6M) |
Pair Trading with Willow Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Willow Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Willow Biosciences will appreciate offsetting losses from the drop in the long position's value.Moving together with Willow Stock
| 0.84 | CMC | Cielo Waste Solutions Earnings Call This Week | PairCorr |
Moving against Willow Stock
The ability to find closely correlated positions to Willow Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Willow Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Willow Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Willow Biosciences to buy it.
The correlation of Willow Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Willow Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Willow Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Willow Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Willow Stock
The Cash Flow Statement is a financial statement that shows how changes in Willow balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Willow's non-liquid assets can be easily converted into cash.